Inactief instrument

Andere talen OUTLOOK THERAPEUTICS, INC. Nasdaq

Aandelen

US68235M1053

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Outlook Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	15/05
Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update	15/05
Outlook Therapeutics Submits Marketing Application for Wet Age-related Macular Degeneration Therapy in UK	13/05
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD	13/05
Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast	09/05
Outlook Therapeutics® to Present at the Retina World Congress 2024	02/05
Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase	29/04
Outlook Therapeutics Announces Closing of Private Placement of $5.0 Million	16/04
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million	15/04
Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC	15/04
Outlook Therapeutics, Inc. announced that it has received $5.000002 million in funding from Syntone Ventures LLC	15/04
Corporate Presentation: March 2024	28/03
North American Morning Briefing : Stocks Set for -2-	28/03
Outlook Therapeutics Shares Rise After BTIG Upgrade	27/03
Outlook Therapeutics Reports Secondary Share Offering	25/03
Outlook Therapeutics Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD	25/03
Sector Update: Health Care Stocks Ease Late Afternoon	22/03
Sector Update: Health Care Stocks Ease Friday Afternoon	22/03
Sector Update: Health Care Stocks Steady Pre-Bell Friday	22/03
Outlook Therapeutics Gets EMA Panel Positive Opinion for Wet AMD Treatment -- Shares Rise Pre-Bell	22/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen OUTLOOK THERAPEUTICS, INC. Nasdaq

Aandelen

US68235M1053

Andere talen

Filters